Procurement Summary
Country: Hungary
Summary: It holds active substances subject to specific accounting. increase in quantities covered by contracts concluded with medicinal products - Stelara
Deadline: 19 Jan 2018
Posting Date: 09 Jan 2018
Other Information
Notice Type: Tender
TOT Ref.No.: 19631879
Document Ref. No.: 16524/2017
Competition: ICB
Financier: European Union (EU)
Purchaser Ownership: -
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Title:- It holds active substances subject to specific accounting. increase in quantities covered by contracts concluded with medicinal products - Stelara
Description:The National Health Insurance Fund as a contracting authority is published in the Official Journal of the European Union, with a call for expressions of interest published on the Sept. 08, 2015 / S 173-314609, CVIII of 2011 on Public Procurement. (1) (a) of the Act of Accessiona negotiated public procurement procedure for the publication of a contract for the procurement of active substances for intrinsic inflammatory disease from 1 November 2015 to 31 October 2017 for a period of 11 months. As a result of the process, On December 22nd, 2015, Hungaropharma Pharmaceuticals Ltd. (1061 Budapest, Kirly u. 12.) and Janssen-Cilag Pharmaceutical Marketing Service Ltd. (1123 Budapest, Nagyenyed u. 8-14.) concluded a contract with F042 / 75-142 / 2015th numbered, the net A framework agreement valid until the deadline of HUF 2 542 475 000, but not later than February 28, 2018.
Announcement Type:- Information on modification of the contract / 2015 EUHL
Place of performance:- HU11, HU1, HU2, HU3
Documents
Tender Notice